22 May 2013
Keywords: NovAliX, Teijin Pharma, Drug discovery
Article | 13 January 2012
French company NovAliX has entered into a multi-target integrated drug discovery collaboration with Japanese drugmaker Teijin Pharma (TYO: 3401), the company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 2012
12 January 2012
© 2013 thepharmaletter.com